ATE119769T1 - Hornhautbehandlungsstoffe. - Google Patents

Hornhautbehandlungsstoffe.

Info

Publication number
ATE119769T1
ATE119769T1 AT92303380T AT92303380T ATE119769T1 AT E119769 T1 ATE119769 T1 AT E119769T1 AT 92303380 T AT92303380 T AT 92303380T AT 92303380 T AT92303380 T AT 92303380T AT E119769 T1 ATE119769 T1 AT E119769T1
Authority
AT
Austria
Prior art keywords
compositions
therapy
aliphatic alcohols
treatment substances
eye
Prior art date
Application number
AT92303380T
Other languages
English (en)
Inventor
David F Muller
Original Assignee
Summit Technology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Summit Technology Inc filed Critical Summit Technology Inc
Application granted granted Critical
Publication of ATE119769T1 publication Critical patent/ATE119769T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT92303380T 1991-04-23 1992-04-15 Hornhautbehandlungsstoffe. ATE119769T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/690,081 US5098896A (en) 1991-04-23 1991-04-23 Corneal treatment agents

Publications (1)

Publication Number Publication Date
ATE119769T1 true ATE119769T1 (de) 1995-04-15

Family

ID=24771001

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92303380T ATE119769T1 (de) 1991-04-23 1992-04-15 Hornhautbehandlungsstoffe.

Country Status (9)

Country Link
US (1) US5098896A (de)
EP (1) EP0514009B1 (de)
JP (1) JPH0672865A (de)
AT (1) ATE119769T1 (de)
AU (1) AU662315B2 (de)
CA (1) CA2066842A1 (de)
DE (1) DE69201674T2 (de)
DK (1) DK0514009T3 (de)
ES (1) ES2073245T3 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5360611A (en) * 1988-10-03 1994-11-01 Alcon Laboratories, Inc. Pharmaceutical compositions and methods of treatment of the cornea following ultraviolet laser irradiation
US5271939A (en) * 1988-10-03 1993-12-21 Alcon Laboratories, Inc. Pharmaceutical compositions and methods of treatment to prevent and treat corneal scar formation produced by laser irradiation
US5624893A (en) * 1993-10-14 1997-04-29 Alcon Laboratories, Inc. Pharmaceutical compositions and methods of treatment of the cornea following laser irradiation
DE69435067T2 (de) * 1993-12-13 2008-05-15 Avanir Pharmaceuticals, La Jolla Formulierungen aus n-docosanol und saccharoseestern
US7214394B2 (en) * 2002-05-31 2007-05-08 Archer-Daniels-Midland Company Policosanol compositions, extraction from novel sources, and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3584115A (en) * 1968-05-31 1971-06-08 Arthur Ira Gebhart Method of applying visible aerosol compositions
SE375007B (de) * 1972-11-30 1975-04-07 Pharmacia Ab
DK243084A (da) * 1983-05-26 1984-11-27 Takeda Chemical Industries Ltd Perkutane farmaceutiske praeparater til udvortes brug
US4678663A (en) * 1984-02-06 1987-07-07 Nuetrogena Corporation Hydroquinone composition having enhanced bio-availability and percutaneous adsorption
US4874794A (en) * 1989-04-28 1989-10-17 Lidak Biopharmaceuticals Inflammatory disease treatment

Also Published As

Publication number Publication date
CA2066842A1 (en) 1992-10-24
US5098896A (en) 1992-03-24
DE69201674T2 (de) 1995-10-26
EP0514009B1 (de) 1995-03-15
AU662315B2 (en) 1995-08-31
EP0514009A1 (de) 1992-11-19
DE69201674D1 (de) 1995-04-20
ES2073245T3 (es) 1995-08-01
AU1217392A (en) 1992-10-29
DK0514009T3 (da) 1995-08-07
JPH0672865A (ja) 1994-03-15

Similar Documents

Publication Publication Date Title
Norris The effect of carbon dioxide laser surgery on the recurrence of keloids
Van Sickels et al. Parotid duct injuries
PT1173198E (pt) Utilizacao de uma determinada hialuronidase para eliminar as cicatrizes a opacificacao e a nevoa corneais
ATE114470T1 (de) Behandlung von intraocularem druck mit einer synergistischen kombination zur ophthalmischen verwendung.
DE69201674D1 (de) Hornhautbehandlungsstoffe.
Xie et al. Lip and perioral trauma: principles of aesthetic and functional reconstruction
WO1995016435A3 (en) Improved intraocular irrigating solution containing non-steroidal antiinflammatory agent
ATE191342T1 (de) Verwendung von riluzol zur behandlung mitochondrialer erkrankungen
Duffy et al. The role of sclerotherapy in abnormal varicose hand veins
DE69106777D1 (de) Behandlung von intraokularem Druck mit einer ophthalmischen synergistischen Kombination.
Bellack et al. Management of facial angiofibromas in tuberous sclerosis: use of the carbon dioxide laser
ATE91419T1 (de) Synergistische kombination zur ophthalmischen verwendung.
US5296514A (en) Corneal treatment agents
DE69431430D1 (de) Faktor XIII zur Behandlung von Hautwunden
Crikelair Surgical approach to facial scarring
KR930021214A (ko) 안질환의 치료 또는 예방을 위한 제약학적 조성물
Tiffee et al. Multiple cutaneous leiomyomas: Report of a case
AU643772B2 (en) Use of hexetidine or its derivatives or salts for the preparation of a pharmaceutical composition for ophthalmological use
RU94022797A (ru) Способ хирургической коррекции миопической анизометропии
聂纯一 et al. CLINICAL OBSERVATION ON THE EFFICACY OF 764-1 EYEDROPS IN TREATMENT OF CORNEAL SCARS
Marsden Care of patients with minor eye trauma
Davenport The windshield injury
RU93025693A (ru) Способ хирургического лечения близорукости
STRAUB The Advent of LASIK
WEYMANN KERATOCENTESIS IN INFECTED WOUNDS OF THE EYEBALL.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
REN Ceased due to non-payment of the annual fee